ALK rearrangement has also been identified in 0.4% to 2.5% of colorectal carcinoma (CRC) by exon array profiling [4], fluorescence in situ hybridization (FISH) [5], and next generation sequencing (NGS) [6] assays performed on archival tumor specimens. Here, ALK is linked to colorectal carcinoma.